JPS61112054A - 新規放射性薬剤およびその製造に有用なキレ−ト化剤 - Google Patents
新規放射性薬剤およびその製造に有用なキレ−ト化剤Info
- Publication number
- JPS61112054A JPS61112054A JP60160039A JP16003985A JPS61112054A JP S61112054 A JPS61112054 A JP S61112054A JP 60160039 A JP60160039 A JP 60160039A JP 16003985 A JP16003985 A JP 16003985A JP S61112054 A JPS61112054 A JP S61112054A
- Authority
- JP
- Japan
- Prior art keywords
- formulas
- tables
- formula
- mathematical
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Conversion Of X-Rays Into Visible Images (AREA)
- Luminescent Compositions (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63238384A | 1984-07-19 | 1984-07-19 | |
| US632383 | 1984-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS61112054A true JPS61112054A (ja) | 1986-05-30 |
Family
ID=24535323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60160039A Pending JPS61112054A (ja) | 1984-07-19 | 1985-07-19 | 新規放射性薬剤およびその製造に有用なキレ−ト化剤 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0191788A1 (enExample) |
| JP (1) | JPS61112054A (enExample) |
| KR (1) | KR900008168B1 (enExample) |
| AU (1) | AU4632085A (enExample) |
| CA (1) | CA1266864A (enExample) |
| DK (1) | DK124686A (enExample) |
| ES (2) | ES8700236A1 (enExample) |
| FI (1) | FI861119A7 (enExample) |
| GR (1) | GR851793B (enExample) |
| IL (1) | IL75845A0 (enExample) |
| NO (1) | NO860980L (enExample) |
| PT (1) | PT80842B (enExample) |
| WO (1) | WO1986000897A1 (enExample) |
| ZA (1) | ZA855477B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007528835A (ja) * | 2003-02-28 | 2007-10-18 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 金属キレートアフィニティリガンドの合成方法 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5071636A (en) * | 1987-12-29 | 1991-12-10 | Nihon Medi-Physics Co., Ltd. | Chelating compounds and their use |
| KR101033209B1 (ko) * | 2004-12-31 | 2011-05-06 | 주식회사 효성 | 분사성을 향상시킨 폴리에스테르 분섬사의 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444690A (en) * | 1982-02-25 | 1984-04-24 | University Patents, Inc. | Technetium chelates |
| AU567433B2 (en) * | 1982-05-18 | 1987-11-19 | University Of Florida | Specific drug delivery |
-
1985
- 1985-07-15 EP EP85903750A patent/EP0191788A1/en not_active Withdrawn
- 1985-07-15 AU AU46320/85A patent/AU4632085A/en not_active Abandoned
- 1985-07-15 WO PCT/US1985/001333 patent/WO1986000897A1/en not_active Ceased
- 1985-07-18 GR GR851793A patent/GR851793B/el unknown
- 1985-07-18 IL IL75845A patent/IL75845A0/xx unknown
- 1985-07-18 KR KR8505136A patent/KR900008168B1/ko not_active Expired
- 1985-07-19 ZA ZA855477A patent/ZA855477B/xx unknown
- 1985-07-19 PT PT80842A patent/PT80842B/pt unknown
- 1985-07-19 CA CA000487166A patent/CA1266864A/en not_active Expired - Lifetime
- 1985-07-19 JP JP60160039A patent/JPS61112054A/ja active Pending
- 1985-07-19 ES ES545395A patent/ES8700236A1/es not_active Expired
-
1986
- 1986-02-17 ES ES552090A patent/ES8705389A1/es not_active Expired
- 1986-03-14 NO NO860980A patent/NO860980L/no unknown
- 1986-03-18 DK DK124686A patent/DK124686A/da not_active Application Discontinuation
- 1986-03-18 FI FI861119A patent/FI861119A7/fi not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007528835A (ja) * | 2003-02-28 | 2007-10-18 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 金属キレートアフィニティリガンドの合成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ES552090A0 (es) | 1987-05-01 |
| FI861119A0 (fi) | 1986-03-18 |
| PT80842B (en) | 1987-05-27 |
| FI861119A7 (fi) | 1986-03-18 |
| PT80842A (en) | 1985-08-01 |
| NO860980L (no) | 1986-05-06 |
| GR851793B (enExample) | 1985-11-26 |
| ES8705389A1 (es) | 1987-05-01 |
| IL75845A0 (en) | 1985-11-29 |
| KR900008168B1 (en) | 1990-11-05 |
| ZA855477B (en) | 1987-03-25 |
| ES545395A0 (es) | 1986-10-01 |
| AU4632085A (en) | 1986-02-25 |
| KR870000935A (ko) | 1987-03-10 |
| EP0191788A1 (en) | 1986-08-27 |
| DK124686D0 (da) | 1986-03-18 |
| ES8700236A1 (es) | 1986-10-01 |
| WO1986000897A1 (en) | 1986-02-13 |
| DK124686A (da) | 1986-05-20 |
| CA1266864A (en) | 1990-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008203856B8 (en) | Stilbene derivatives and their use for binding and imaging amyloid plaques | |
| AU2009278279B2 (en) | DAA-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment | |
| AU2002323417A1 (en) | Stilbene derivatives and their use for binding and imaging amyloid plaques | |
| US4963688A (en) | Compounds for site-enhanced delivery of radionuclides and uses thereof | |
| WO1992012978A1 (fr) | Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique | |
| US4963682A (en) | Novel radiopharmaceuticals and chelating agents useful in their preparation | |
| WO1995001346A1 (en) | Chelating compounds | |
| EP1553985A2 (en) | Biphenyls and fluorenes as imaging agents in alzheimer's disease | |
| JPS61112054A (ja) | 新規放射性薬剤およびその製造に有用なキレ−ト化剤 | |
| WO1992019274A1 (en) | Technetium chelates to be used for determining the renal function | |
| AU2014200012C1 (en) | N-alkoxyamide conjugates as imaging agents | |
| KR900007514B1 (ko) | 금속 방사성 핵종과 함께 킬레이트 할수 있는 염 | |
| DE19860289C2 (de) | Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium | |
| US5136038A (en) | Radiopharmaceuticals and chelating agents useful in their preparation | |
| EP1379499B1 (en) | New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition | |
| US7731936B2 (en) | Metal complexes based on tetrathiol ligands and their use in nuclear medical diagnostics and endoradionuclide therapy and method for producing said metal complexes | |
| Jackson et al. | Rhenium diamino dithiol complexes. III. Lipophilic ligands for endotherapeutic radiopharmaceuticals | |
| AU3230993A (en) | Technetium-99m complexes with n-substituted 3-hydroxy-4-pyridinones | |
| JPH0237345B2 (enExample) | ||
| DE4425781A1 (de) | Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel | |
| NZ263793A (en) | Compounds suitable for forming tc and re chelates, radiopharmaceutical compositions thereof | |
| US5155227A (en) | Compounds for site-enhanced delivery of radionuclides | |
| KR101427292B1 (ko) | 허혈성 조직 영상을 위한 플루오르―18 표지 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염 | |
| WO2024023332A1 (en) | Silicon-based fluoride acceptor groups for radiopharmaceuticals |